Richard Herdener, MD
Dermatology · Spokane, WANPI 1457326365
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.9% of the total across 133 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AbbVie at 29.9% of the total. Reporting peaked in 2019 at $966 and has fallen 62.3% since, to $364 in 2025.
Across 133 payments — averaging $27.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$356
- Pfizer$273
- Johnson & Johnson$215
- Sun Pharmaceutical Industries Inc.$195
- Amgen$192
- plus $1K from 19 others
Across 51 payments — averaging $1452.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Vanda Pharmaceuticals Inc.$35K
- Sun Pharmaceutical Industries Inc.$27K
- Novartis$11K
- Dermavant Sciences, Inc.$807
What the payments were for
- Food & beverage$3,50596%
- Education$1514%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 37 | $1,092 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 17 | $356 |
| Pfizer | 9 | $273 |
| Johnson & Johnson | 6 | $215 |
| Sun Pharmaceutical Industries Inc. | 4 | $195 |
| Amgen | 8 | $192 |
| Lilly USA, LLC | 10 | $187 |
| Revance Therapeutics, Inc. | 1 | $140 |
| LEO Pharma Inc. | 2 | $137 |
| Galderma Laboratories, L.p. | 4 | $128 |
| Regeneron Healthcare Solutions, Inc. | 6 | $120 |
| Incyte Corporation | 2 | $116 |
| UCB, Inc. | 4 | $85 |
| Biofrontera Inc. | 4 | $84 |
| Dermavant Sciences, Inc. | 4 | $67 |
| Organogenesis Inc. | 3 | $61 |
| Novartis | 3 | $40 |
| Almirall LLC | 1 | $36 |
| Sanofi | 2 | $32 |
| Bristol Myers Squibb | 1 | $24 |
| Reprise Biomedical, Inc. | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $16 |
| Genentech USA, Inc. | 1 | $12 |
| Organon | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,656 in reported general payments places this provider in the 75th percentile of 323 dermatology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 14 | $53,418 |
| Betamethasone Dipropionate | 31 | $1,639 |
| Clobetasol Propionate | 31 | $1,243 |
| Metronidazole | 21 | $875 |
| Doxycycline Hyclate | 11 | $150 |
| Prednisone | 11 | $59 |
| Hydrocortisone | 13 | $56 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Spokane
- William WerschlerSpokane$948K
- Cameron ChesnutSpokane$93K
- Joyce ParkSpokane$8K
- James ParkerSpokane$7K
- William WraySpokane$6K
- Brittany UrsoSpokane$5K
- Clive LiuBellevue$2.9M
- Vivian ShiSeattle$971K
- Daniel LevyBonney Lake$541K
- Daniel SugaiBellevue$302K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.